Literature DB >> 19836147

Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1alpha), and transforming growth factors beta1 (TGFbeta1) and beta3 (TGFbeta3) in gestational trophoblastic disease.

F Bolat1, N Haberal, N Tunali, E Aslan, N Bal, I Tuncer.   

Abstract

The aim of this study was to investigate the relationship between the expression of vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-beta1 and TGF-beta3), and hypoxia inducible factor 1 alpha (HIF-1alpha) in gestational trophoblastic diseases to highlight the possible histogenesis. Twenty-one partial hydatidiform moles (PHM), 19 complete hydatidiform moles (CHM), 13 choriocarcinomas, and 20 nonhydropic spontaneous abortions (control group) were evaluated with immunohistochemistry using VEGF, HIF-1alpha, TGFbeta1, and TGFbeta3. The extent of immunohistochemical positivity (0%=0, 1-24%=1, 25-49%=2, 50-74%=3, and greater than 75%=4) and intensity (no staining=0, weak staining=1, medium staining=2, and strong staining=3) were recorded. The expression of VEGF in spontaneous abortions and choriocarcinoma was higher than the expression in PHM and CHM. HIF-1alpha was strongly expressed in the choriocarcinomas compared to the other subgroups. Nonhydropic spontaneous abortions (control group) showed the highest TGFbeta1 expression levels among the case subgroups, followed by PHM, CHM, and choriocarcinoma (p<0.001). The expression of TGFbeta3 was seen in all groups, but the highest level of expression was observed in both CHM and choriocarcinoma. We conclude that higher levels of VEGF, HIF-1alpha, and TGFbeta3 expression in choriocarcinoma might be involved in the development of trophoblastic diseases. Copyright 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19836147     DOI: 10.1016/j.prp.2009.07.017

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.

Authors:  Michelle K Y Siu; Matthew C W Yeung; HuiJuan Zhang; Daniel S H Kong; Joanna W K Ho; Hextan Y S Ngan; Dominic C W Chan; Annie N Y Cheung
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

2.  Hypoxia-inducible factor-1α (HIF-1α) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.

Authors:  Tingfang Yi; Evangelos Papadopoulos; Patrick R Hagner; Gerhard Wagner
Journal:  J Biol Chem       Date:  2013-05-10       Impact factor: 5.157

3.  Choroidal metastases in testicular choriocarcinoma, successful treatment with chemo- and radiotherapy: a case report.

Authors:  Ivo Guber; Leonidas Zografos; Ann Schalenbourg
Journal:  BMC Urol       Date:  2011-12-07       Impact factor: 2.264

Review 4.  The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.

Authors:  Nadia Alfaidy; Pascale Hoffmann; Houssine Boufettal; Naima Samouh; Touria Aboussaouira; Mohamed Benharouga; Jean-Jacques Feige; Sophie Brouillet
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

5.  Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.

Authors:  Flavia Tarabini Castellani Asmar; Antonio Rodrigues Braga-Neto; Jorge de Rezende-Filho; Juliana Marques Simões Villas-Boas; Rafael Cortés Charry; Izildinha Maesta
Journal:  Clinics (Sao Paulo)       Date:  2017-05       Impact factor: 2.365

Review 6.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

7.  Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF‑VEGFR2‑AKT/FAK signal axis.

Authors:  Xinzhi Wang; Xiaoting Fu; Shijun Zhao; Xiaoyan Fu; Huifang Zhang; Lurong Shao; Gang Li; Cundong Fan
Journal:  Mol Med Rep       Date:  2017-10-05       Impact factor: 2.952

Review 8.  Antiviral properties of placental growth factors: A novel therapeutic approach for COVID-19 treatment.

Authors:  Meghnad G Joshi; Jeevitaa Kshersagar; Shashikant R Desai; Shimpa Sharma
Journal:  Placenta       Date:  2020-08-06       Impact factor: 3.481

Review 9.  Computational Models on Pathological Redox Signalling Driven by Pregnancy: A Review.

Authors:  Samprikta Manna; Camino S M Ruano; Jana-Charlotte Hegenbarth; Daniel Vaiman; Shailendra Gupta; Fergus P McCarthy; Céline Méhats; Cathal McCarthy; Clara Apicella; Julia Scheel
Journal:  Antioxidants (Basel)       Date:  2022-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.